Literature DB >> 27203786

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology.

Zubair W Baloch1, Raja R Seethala2, William C Faquin3, Mauro G Papotti4, Fulvio Basolo5, Guido Fadda6, Gregory W Randolph7, Steven P Hodak8, Yuri E Nikiforov2, Susan J Mandel9.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27203786     DOI： 10.1002/cncy.21744

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN： 1934-662X            Impact factor:   5.284


× No keyword cloud information.
  22 in total

1.  Accuracy of Fine Needle Cytology in Histological Prediction of Papillary Thyroid Carcinoma Variants: a Prospective Study.

Authors:  Anna Cipolletta Campanile; Maria Gabriella Malzone; Nunzia Simona Losito; Gerardo Botti; Maria Grazia Chiofalo; Antongiulio Faggiano; Roberta Siciliano; Annamaria Colao; Luciano Pezzullo; Franco Fulciniti
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

Review 2.  Molecular markers in well-differentiated thyroid cancer.

Authors:  Anil K D'Cruz; Richa Vaish; Abhishek Vaidya; Iain J Nixon; Michelle D Williams; Vincent Vander Poorten; Fernando López; Peter Angelos; Ashok R Shaha; Avi Khafif; Alena Skalova; Alessandra Rinaldo; Jennifer L Hunt; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-06       Impact factor: 2.503

Review 3.  Molecular profiling of thyroid nodule fine-needle aspiration cytology.

Authors:  Markus Eszlinger; Lorraine Lau; Sana Ghaznavi; Christopher Symonds; Shamir P Chandarana; Moosa Khalil; Ralf Paschke
Journal:  Nat Rev Endocrinol       Date:  2017-03-31       Impact factor: 43.330

4.  Evaluation of the Italian cytological subclassification of thyroid indeterminate nodules into TIR-3A and TIR-3B: a retrospective study of 290 cases with histological correlation from a single institution.

Authors:  E Rullo; G Minelli; D Bosco; F Nardi; V Ascoli
Journal:  J Endocrinol Invest       Date:  2017-09-25       Impact factor: 4.256

Review 5.  Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists.

Authors:  Raja R Seethala; Zubair W Baloch; Justine A Barletta; Elham Khanafshar; Ozgur Mete; Peter M Sadow; Virginia A LiVolsi; Yuri E Nikiforov; Giovanni Tallini; Lester Dr Thompson
Journal:  Mod Pathol       Date:  2017-10-20       Impact factor: 7.842

Review 6.  Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Historical Context, Diagnosis, and Future Challenges.

Authors:  Bin Xu; Giovanni Tallini; Ronald A Ghossein
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

7.  Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology.

Authors:  Pablo Valderrabano; Laila Khazai; Marino E Leon; Zachary J Thompson; Zhenjun Ma; Christine H Chung; Julie E Hallanger-Johnson; Kristen J Otto; Kara D Rogers; Barbara A Centeno; Bryan McIver
Journal:  Endocr Relat Cancer       Date:  2017-01-19       Impact factor: 5.678

8.  Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP): a 13-year retrospective review at Jordan University Hospital.

Authors:  Rajai O Zurikat; Majd Khader; Muayad I Azzam; Zaid M Zahid; Samer F Daoud; Salam F Nusirat; Nader Albsoul; Motaz A Al-Natsheh; Mousa A Al-Abbadi
Journal:  Endocrine       Date:  2020-04-22       Impact factor: 3.633

9.  Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia.

Authors:  Roberto Bellelli; Donata Vitagliano; Giorgia Federico; Pina Marotta; Anna Tamburrino; Paolo Salerno; Orlando Paciello; Serenella Papparella; Jeffrey A Knauf; James A Fagin; Samuel Refetoff; Giancarlo Troncone; Massimo Santoro
Journal:  Mol Cell Endocrinol       Date:  2017-06-23       Impact factor: 4.102

10.  Reclassification as NIFTP: a Retrospective Review in a Single Institution with an Emphasis on Workload.

Authors:  Kevin O'Hare; E O'Regan; A Khattak; M L Healy; M Toner
Journal:  Endocr Pathol       Date:  2018-09       Impact factor: 3.943
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.